Structural mobility of antithrombin and its modulation by heparin

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 516-519

  Carrell, Robin ^a   Skinner, Richard ^a   Jin, Lei ^a   Abrahams, Jan Pieter ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HEPARIN; PENTASACCHARIDE; SERINE PROTEINASE INHIBITOR;

BINDING SITE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG DESIGN; MODULATION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0030792544     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657579     Document Type: Conference Paper

References (12)

1. Bray B, Lane DA, Freyssinet JM, Pejler G, Lindahl U. Antithrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. Biochem. J. 1989;262(1):225-232.
2. Choay J, Petitou M, Lormeau JC, Sinay P, Casu B, Gatti G. Structure activity relationship in heparin : a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Commun. 1983;116:492-499.
3. Lindahl U, Thunberg L, Backstrom G, Riesenfeld J, Nordling K, Bjork I. Extension and structural variability of the antithrombin binding sequence in heparin. J. Biol. Chem. 1984;259:12368-12376.
4. Olson ST, Björk I. Regulation of thrombin by antithrombin and heparin cofactor II. In: Thrombin, Structure and Function. Berliner LJ, ed Plenum Press, New York 1992: pp159-217.
5. Marcum JA, McKenney JB, Galli SJ, Jackman RW, Rosenberg RD. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J. Clin. Invest. 1986;74(2):341-350.
6. Skinner R, Abrahams JP, Whisstock JC, Lesk AM, Carrell RW, Wardell MR. The 2.6Å structure of antithrombin indicates a conformational change at the heparin binding site. J. Mol. Biol. 1997;266:601-609.
7. 1-antitrypsin. Nature Struct. Biol. 1996;3(8):676-681.
8. Jin L, Abrahams JP, Skinner R, Petitou M, Pike R, Carrell R. 2.9Å structures indicate mechanism of heparin binding and activation of antithrombin. Abstract for XVIth Congress of the International Society on Thrombosis and Haemostasis, Florence, June 6-12, 1997.
9. 1-antitrypsin Pittsburgh (358 Met to Arg), a fatal bleeding disorder. N. Eng. J. Med. 1983;309:694-698.
10. Wright HT, Scarsdale JN. Structural basis for serpin inhibitor activity. Proteins 1995;22:210-225.
11. Carrell RW, Christey PB, Boswell DR. Serpins: antithrombin and other inhibitors of coagulation and fibrinolysis; evidence from amino acid sequences. In: Thrombosis and Haemostasis. Verstraets M, Vermylen J, Lijnen HR, Arnout J, eds. Leuven University Press 1987; pp 1-15.
12. Borg JY, Owen MC, Soria C, Soria J, Caen J, Carrell RW. Proposed heparin binding site in antithrombin based on Arginine 47. A new variant Rouen-II, 47Arg to Ser. J. Clin. Invest. 1988;81:1292-1296.